Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Epi-Aids, Meetings, Resistance Report

Division of Bacterial Diseases (DBD) News Bulletin

Fall 2013

Epi-Aids

Group A Streptococcus outbreak – American Samoa, June 2013. The team went to American Samoa to assist the American Samoa Department of Health and Lyndon B. Johnson Tropical Medicine Center with defining the epidemiology of scabies infestation and streptococcal skin infection in the pediatric population.

Legionella outbreak – Columbus, Ohio, July 2013. The team assisted with conducting an epidemiologic and environmental investigation of a Legionnaires' disease outbreak at a retirement community in Ohio. They also provided environmental legionellosis outbreak response training.

Jasen Kunz (NCEH), Laurel Garrison, Sara Tomczyk, Claressa Lucas, and Jeff Mercante

Photo: The CDC team who investigated the Legionnaires’ disease outbreak in Atlanta, GA. Jasen Kunz (NCEH) and DBD/RDB’s Laurel Garrison, Sara Tomczyk, Claressa Lucas, and Jeff Mercante (from left to right).

Legionella outbreak – Atlanta, Georgia, August 2013. The team assisted with conducting an epidemiologic and environmental investigation of a Legionnaires' disease outbreak associated with a family reunion in Georgia. They also provided environmental legionellosis outbreak response training.

Legionella outbreak – Florence, Alabama, October 2013. The team assisted with conducting an epidemiologic and environmental investigation of a Legionnaires' disease outbreak associated with a long-term care facility in Alabama.

Serogroup B meningococcal disease outbreak – Princeton, New Jersey, October 2013. The team assisted with investigating a meningococcal disease outbreak at Princeton University.

Meetings

The 2013 CSTE Annual Conference was held June 9–12, 2013, in Pasadena, CA. DBD participants included Anna Acosta, Amanda Faulkner, and Tami Skoff.

The 10th International Symposium on Bordetella was held September 8–11, 2013, in Dublin, Ireland. Pam Cassiday, Thomas Clark, Amanda Cohn, Rajam Gowrisankar, Stephen Hadler, Stacey Martin, Manisha Patel, Lucia Pawloski, Han Li, Conrad Quinn, Lucia Tondella, and Margaret Williams attended. Visit http://www.bordetella2013.com for more information.

Measuring Short- and Long-Term Vaccine Impact of PCV Meeting was held September 16–20, 2013, in Geneva, Switzerland. Rana Hajjeh, Jennifer Verani, and Cynthia Whitney participated.

NUVI IB-VPD Strategic Review Meeting was held September 16–20, 2013, in Geneva, Switzerland. Rana Hajjeh, Carla Talarico, and Chris Van Beneden attended.

Today’s Drug-Resistant Health Threats
Drug-resistant Health Threats: Estimated minimum number of illnesses and deaths caused annually by antibotic resistance*: At least 2,049,442 illnesses, 23,000 deaths. *bacteria and fungus included in this report.On September 16, CDC issued a landmark report on drug-resistant health threats. Every year, more than two million people in the United States get infections that are resistant to antibiotics and at least 23,000 people die as a result. The report presents a first-ever snapshot of the burden and threats posed by the antibiotic-resistant germs that have the most impact on human health, including three from DBD: Streptococcus pneumoniae, group A Streptococcus, and group B Streptococcus. This report is also the first time that CDC has ranked these threats into categories of urgent, serious, and concerning. Read the report at www.cdc.gov/drugresistance.

 Top of Page
Top